Connecteve successfully closed a 14 billion KRW Series A funding round to advance its AI-driven orthopedic solutions, attracting both existing and new investors.
Target Information
Connecteve, a company specializing in AI-based orthopedic solutions, has recently announced the successful completion of a Series A funding round amounting to 14 billion KRW. This round saw participation from existing investors such as DSC Investment, Stonebridge Ventures, Schmidt, and Reventures, while new investors including BSK Investment, TS Investment, IMM Investment, JB Investment, and Big Move Ventures joined the funding round, bringing the total number of participating venture capital firms to nine.
Connecteve attributes this successful investment to its exceptional technological capabilities and future growth potential, particularly in light of the global economic slowdown and the downturn in the venture investment market. The anticipation surrounding the upcoming launch of AI-powered medical solutions such as CONNEVO KOA, ALI, and Suite is expected to drive innovation in medical practice, offering personalized treatment plans and precise analytical tools for orthopedic surgeons.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in South Korea
The orthopedic medical technology industry in South Korea is experiencing significant growth, spurred by advancements in AI and machine learning applications. The integration of technology into healthcare is reshaping traditional approaches to tr
Similar Deals
한국투자파트너스, IBK기업은행, SBI인베스트먼트, L&S벤처캐피탈, 리인베스트먼트, 오다스톤인베스트먼트 → 레이와트
2025
Codexial, Finovam Gestion, Groupe ILP, Angels Santé, Alsace Business Angels → StemInov
2026
DSC인베스트먼트, 스톤브릿지벤처스, 슈미트, 리벤처스, BSK인베스트먼트, TS인베스트먼트, IMM인베스트먼트, JB인베스트먼트, 빅무브벤처스
invested in
코넥티브
in 2023
in a Series A deal
Disclosed details
Transaction Size: $11M